Kaye Edward M. MD sold STOK
December 5, 2025 · Form 4 insider transaction
Kaye Edward M. MD sold 1,681 shares of Stoke Therapeutics, Inc. at $31.15 per share, a transaction worth $52.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,681
Price
$31.15
Total value
$52.4K
InsiderKaye Edward M. MD
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 5, 2025
Filing dateDecember 5, 2025
Shares owned after63,054
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.69 to $31.61 per share, inclusive.